Altana Omnaris Adrenal Function Assessment Was “Not Ideal,” FDA Says
Executive Summary
Study design deficiencies impeded Altana's attempt to distinguish Omnaris (ciclesonide) from other nasal corticosteroids as having less potential to suppress the cortisol system and adrenal function